News and Announcements
SuiteBox Announces Deal with Aon
- Published June 05, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Fintech firm SuiteBox has announced a deal with Aon Australia to provide financial advisers with digital client engagement tools.
KEY TAKEAWAYS:
- Announcing the deal, Aon general manager of financial advice Jayson Walker said that leveraging video conferencing technology like SuiteBox is “the next logical step in improving the client experience”.
“It also increases the effectiveness and efficiencies for our adviser’s practices,” Mr Walker said.
“A key innovation from SuiteBox was the integration of the digital signatures into the video conference itself.
“To have an adviser be able to digitally present a statement of advice and capture the authority to proceed in the same session is the kind of easy and simple process consumers have come to expect.”
SuiteBox chief executive Ian Dunbar said, “[Aon] undertook a comprehensive review of functionality, risk and suitability, and I am very proud that SuiteBox has been selected by Aon to deliver a comprehensive digital workspace to their advisers and clients.
“From our inception, SuiteBox has always understood the importance of the ability to not only meet, but also collaborate on documents and transact business all in the one digital solution.”
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
